1.
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
by Ortiz, Alberto, Prof
The Lancet (British edition), 2014, Vol.383 (9931), p.1831-1843
2.
Left Ventricular Mass Index as an Outcome Measure in Clinical Trials in Dialysis Patients: A Word of Caution
by Zoccali, Carmine
American journal of nephrology, 2011-04, Vol.33 (4), p.370-372
3.
The double challenge of resistant hypertension and chronic kidney disease
by Rossignol, Patrick, Prof
The Lancet (British edition), 2015, Vol.386 (10003), p.1588-1598
4.
Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease
by Tamez, Hector, MD, MPH
The American heart journal, 2012, Vol.164 (6), p.902-909.e2
5.
The role of minimally invasive lateral lumbar interbody fusion in sagittal balance correction and spinal deformity
by Costanzo, Giuseppe
European spine journal, 2014-09-13, Vol.23 (Suppl 6), p.699-704
6.
18F-FDG PET/CT in the evaluation of cartilaginous bone neoplasms: the added value of tumor grading
by Annovazzi, Alessio
Annals of nuclear medicine, 2019-08-08, Vol.33 (11), p.813-821
7.
Dialysis The sweetness of glitazones: randomized trials needed
by Zoccali, Carmine
Nature reviews. Nephrology, 2009-09, Vol.5 (9), p.497-498
8.
Epithelioid hemangioendothelioma of the spine: results at seven years of average follow-up in a series of 10 cases surgically treated and a review of literature
by Luzzati, Alessandro
European spine journal, 2014-08-15, Vol.24 (10), p.2156-2164
9.
Sodium and cardiovascular disease
by Strazzullo, Pasquale
The Lancet (British edition), 2016, Vol.388 (10056), p.2111-2111
10.
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
by Zoccali, Carmine
The Lancet (British edition), 2001-12-22, Vol.358 (9299), p.2113-2117
11.
The challenge of Mendelian randomization approach
by Zoccali, Carmine
Current medical research and opinion, 2017-11-17, Vol.33 (sup3), p.5-8
12.
The Role of Deconditioning in the End-Stage Renal Disease Myopathy: Physical Exercise Improves Altered Resting Muscle Oxygen Consumption
by Manfredini, Fabio
American journal of nephrology, 2015-07, Vol.41 (4-5), p.329-336
13.
Sarcoma patients’ quality of life from diagnosis to yearly follow-up: experience from an Italian tertiary care center
by Maggi, Gabriella
Future oncology (London, England), 2019-09-01, Vol.15 (27), p.3125-3134
14.
Obesity and kidney disease: hidden consequences of the epidemic
by Kovesdy, Csaba P
Pediatric nephrology (Berlin, West), 2017-02-01, Vol.32 (4), p.537-545
15.
Longitudinal Analysis of Vascular Function and Biomarkers of Metabolic Bone Disorders before and after Renal Transplantation
by Yilmaz, Mahmut Ilker
American journal of nephrology, 2013-03, Vol.37 (2), p.126-134
16.
Ramipril Lowers Plasma FGF-23 in Patients with Diabetic Nephropathy
by Yilmaz, Mahmut Ilker
American journal of nephrology, 2014-10, Vol.40 (3), p.208-214
17.
Left Ventricular Systolic Dysfunction: A Sudden Killer in End-Stage Renal Disease Patients
by Zoccali, Carmine
Hypertension (Dallas, Tex. 1979), 2010-08, Vol.56 (2), p.187-188
18.
Snoring Amplifies the Risk of Heart Failure and Mortality in Dialysis Patients
by Torino, Claudia
American journal of nephrology, 2014-07, Vol.39 (6), p.536-542
19.
Long-Term Progression of Coronary Artery Calcification Is Independent of Classical Risk Factors, C-Reactive Protein, and Parathyroid Hormone in Renal Transplant Patients
by Gulcicek, Sibel
Cardiorenal medicine, 2017-10, Vol.7 (4), p.284-294
20.
Low Triiodothyronine Alters Flow-Mediated Vasodilatation in Advanced Nondiabetic Kidney Disease
by Yilmaz, Mahmut Ilker
American journal of nephrology, 2011-01, Vol.33 (1), p.25-32
